Hospital de Messejana dr. Carlos Alberto Studart Gomes
Fortaleza, Brazil
Hospital in Fortaleza, State of Ceará
Av. Frei Cirilo, 3480 - Messejana, Fortaleza - CE, 60840-285
About Hospital de Messejana dr. Carlos Alberto Studart Gomes
"O Hospital de Messejana Dr. Carlos Alberto Studart Gomes (HM) é uma unidade pública, da Secretaria de Saúde do Ceará (Sesa), especializada no diagnóstico e tratamento de doenças cardíacas e pulmonares."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Hospital Israelita Albert Einstein
2
Janssen Research & Development, LLC
2
Actelion
1
Pfizer
1
Clinical Trials at Hospital de Messejana dr. Carlos Alberto Studart Gomes
During the past decade, Hospital de Messejana dr. Carlos Alberto Studart Gomes conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
2011-11-01
2015-01-01
Completed
8,144
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
2018-11-29
2022-04-18
Terminated
246
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
2019-01-23
2022-06-07
Terminated
131
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
2020-03-28
2020-06-14
Completed
440
PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial
2020-10-15
2024-01-30
Recruiting
3,400
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
2021-09-06
2022-03-18
Terminated
28
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hospital Israelita Albert Einstein" with 2 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Messejana dr. Carlos Alberto Studart Gomes"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "EMS" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hospital Sirio-Libanes" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hospital de Messejana dr. Carlos Alberto Studart Gomes
According to Clinical.Site data, the most researched conditions in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are
"Acute Coronary Syndrome" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Coronavirus Infections" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" in a lesser frequency.
Clinical Trials Intervention Types at Hospital de Messejana dr. Carlos Alberto Studart Gomes
Most popular intervention types in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Antiplatelet Monotherapy" (1 trials), "Hydroxychloroquine" (1 trials) and "Hydroxychloroquine + azithromycin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital de Messejana dr. Carlos Alberto Studart Gomes
The vast majority of trials in "Hospital de Messejana dr. Carlos Alberto Studart Gomes" are
8 trials for "All" genders.
Clinical Trials Status at Hospital de Messejana dr. Carlos Alberto Studart Gomes
Currently, there are NaN active trials in "Hospital de Messejana dr. Carlos Alberto Studart Gomes".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hospital de Messejana dr. Carlos Alberto Studart Gomes,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Messejana dr. Carlos Alberto Studart Gomes, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".